Virbac: Solid growth of +7.4% at CERS in H1 2026, fueled by double-digit growth of our Supercharge platforms

EarningsPositive

AI Analysis

Summary

Virbac reported H1 2026 revenue of €768m, representing 7.4% growth at constant exchange rates and scope versus H1 2025. Growth was balanced across both segments with companion animal up 10.0% and farm animal up 6.7%.

Financial Highlights

Revenue

€768m

Importance:3/10

Sentiment:

0.60

earningsH1 2026revenue growthcompanion animalfarm animal

Related Companies

$SLDB $TRAX

Read the original article

Published by PR Newswire Pharma on July 20, 2026 6:43 PM

Read Original